These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1200759)

  • 1. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.
    Maas JW
    Arch Gen Psychiatry; 1975 Nov; 32(11):1357-61. PubMed ID: 1200759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 4. MHPG excretion by patients with affective disorders.
    Maas JW; Dekirmenjian H; Fawcett JA
    Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW
    Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536
    [No Abstract]   [Full Text] [Related]  

  • 6. Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
    van Praag HM
    Compr Psychiatry; 1980; 21(1):44-54. PubMed ID: 6987035
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin.
    Zis AP; Goodwin FK
    Arch Gen Psychiatry; 1979 Sep; 36(10):1097-1107. PubMed ID: 475543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 9. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
    Schildkraut JJ
    Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 11. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry.
    Schildkraut JJ
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):98-107. PubMed ID: 4438430
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Hydroxytryptamine in depression.
    Pare CM; Trenchard A; Turner P
    Adv Biochem Psychopharmacol; 1974; 11(0):275-9. PubMed ID: 4846267
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine metabolism, depressive illness, and drug response.
    Maas JW; Fawcett JA; Dekirmenjian H
    Arch Gen Psychiatry; 1972 Mar; 26(3):252-62. PubMed ID: 4551050
    [No Abstract]   [Full Text] [Related]  

  • 15. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical aspects of human behaviour (author's transl)].
    Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856
    [No Abstract]   [Full Text] [Related]  

  • 17. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.
    Potter WZ
    Drugs; 1984 Aug; 28(2):127-43. PubMed ID: 6205841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies of a new antidepressive agent, nortriptyline].
    Ropert R; Sivadon P
    Ann Med Psychol (Paris); 1967 May; 125(5):744-50. PubMed ID: 6064542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current biochemical hypotheses of endogenous depression].
    Riederer P; Beckmann H; Brücke T
    Wien Klin Wochenschr; 1985 Feb; 97(4):190-6. PubMed ID: 2580396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.